| [1] |
Qian Z, Shen Q, Yang X, et al.The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment[J]. Biomed Res Int, 2015, 2015: 649161-649168.
|
| [2] |
Slaby O, Svoboda M, Michalek J, et al.MicroRNAs in colorectal cancer: translation of molecular biology into clinical application[J]. Mol Cancer, 2009, 8(1): 102-114.
|
| [3] |
Igaz I and Topa L. [Significance of microRNA expression in body fluids in the diagnosis of gastrointestinal tumors][J]. Orv Hetil, 2014, 155(1): 11-15.
|
| [4] |
Esteller M. Non-coding RNAs in human disease[J]. Nat Rev Genet, 2011, 12(12): 861-874.
|
| [5] |
Dandri M and Locarnini S. New insight in the pathobiology of hepatitis B virus infection[J]. Gut, 2012, 61(Suppl 1): i6-i17.
|
| [6] |
Loggi E, Gamal N, Bihl F, et al.Adaptive response in hepatitis B virus infection[J]. J Viral Hepat, 2014, 21(5): 305-313.
|
| [7] |
Wang G, Dong F, Xu Z, et al.MicroRNA profile in HBV-induced infection and hepatocellular carcinoma[J]. BMC Cancer, 2017, 17(1): 805-815.
|
| [8] |
Xu J, Wu C, Che X, et al.Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis[J]. Mol Carcinog, 2011, 50(2): 136-142.
|
| [9] |
Zhang H, Li QY, Guo ZZ, et al.Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B[J]. World J Gastroenterol, 2012, 18(37): 5188-5196.
|
| [10] |
Li JF, Dai XP, Zhang W, et al.Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H[J]. MBio, 2015, 6(2): e02459-02464.
|
| [11] |
Wang Y, Li Y. miR-146 promotes HBV replication and expression by targeting ZEB2[J]. Biomed Pharmacother, 2018, 99(3): 576-582.
|
| [12] |
Xing T, Zhu J, Xian J, et al.miRNA-548ah promotes the replication and expression of hepatitis B virus by targeting histone deacetylase 4[J]. Life Sci, 2019, 219(4): 199-208.
|
| [13] |
Nielsen KO, Jacobsen KS, Mirza AH, et al.Hepatitis B virus upregulates host microRNAs that target apoptosis-regulatory genes in an in vitro cell model[J]. Exp Cell Res, 2018, 371(1): 92-103.
|
| [14] |
Zhao F, Xu G, Zhou Y, et al.MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein[J]. J Biol Chem, 2014, 289(50): 35029-35041.
|
| [15] |
Shih C, Chou SF, Yang CC, et al.Control and Eradication Strategies of Hepatitis B Virus[J]. Trends Microbiol, 2016, 24(9): 739-749.
|
| [16] |
Wang Y, Tian H. miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines[J]. Biochem Biophys Res Commun, 2017, 487(1): 167-172.
|
| [17] |
Chalasani N, Younossi Z, Lavine JE, et al.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357.
|
| [18] |
Dowman JK, Tomlinson JW, Newsome PN.Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J]. Aliment Pharmacol Ther, 2011, 33(5): 525-540.
|
| [19] |
Zheng X, Gong L, Luo R, et al.Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults[J]. Lipids Health Dis, 2017, 16(1): 202-208.
|
| [20] |
Michelotti GA, Machado MV, Diehl AM.NAFLD, NASH and liver cancer[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(11): 656-665.
|
| [21] |
Katsura A, Morishita A, Iwama H, et al.MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis[J]. Int J Mol Med, 2015, 35(4): 877-884.
|
| [22] |
Afonso MB, Rodrigues PM, Simao AL, et al.Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma[J]. J Clin Med, 2016, 5(3): 30-49.
|
| [23] |
Hu J, Xu Y, Hao J, et al.MiR-122 in hepatic function and liver diseases[J]. Protein Cell, 2012, 3(5): 364-371.
|
| [24] |
Liu CH, Ampuero J, Gil-Gomez A, et al.miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis[J]. J Hepatol, 2018, 69(6): 1335-1348.
|
| [25] |
Clarke JD, Sharapova T, Lake AD, et al.Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis[J]. J Appl Toxicol, 2014, 34(6): 726-732.
|
| [26] |
Pirola CJ, Fernandez Gianotti T, Castano GO, et al.Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis[J]. Gut, 2015, 64(5): 800-812.
|
| [27] |
Wu GY, Rui C, Chen JQ, et al.MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1[J]. Cell Physiol Biochem, 2017, 44(4): 1651-1664.
|
| [28] |
Management of liver cirrhosis[J]. Lancet, 2014, 383(9930): 1694-1694.
|
| [29] |
Heidelbaugh JJ and Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation[J]. Am Fam Physician, 2006, 74(5): 756-762.
|
| [30] |
Ganem D and Prince AM.Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
|
| [31] |
Guo L, Li W, Hu L, et al.Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis[J]. Oncotarget, 2018, 9(4): 5397-5405.
|
| [32] |
Lopez-Riera M, Conde I, Quintas G, et al.Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers[J]. Sci Rep, 2018, 8(1): 10606.
|
| [33] |
Riazalhosseini B, Mohamed R, Apalasamy YD, et al.Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B[J]. Rev Soc Bras Med Trop, 2017, 50(2): 161-166.
|
| [34] |
Shaheen NMH, Zayed N, Riad NM, et al.Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients [J]. Virus Res, 2018, 255(16): 77-84.
|
| [35] |
Yan G, Li B, Xin X, et al.MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1[J]. Med Sci Monit, 2015, 21(10): 3008-3015.
|
| [36] |
Fernandez-Ramos D, Fernandez-Tussy P, Lopitz-Otsoa F, et al. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis[J]. Cell Death Dis, 2018, 9(10): 958-973.
|
| [37] |
Farrar C, Clarke S. Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of L-isoaspartyl (D- Aspartyl) O-methyltransferase-deficient mice[J]. J Biol Chem, 2002, 277(31): 27856-27863.
|
| [38] |
Ma L, Ma J, Ou HL.MicroRNA219 overexpression serves a protective role during liver fibrosis by targeting tumor growth factor beta receptor 2[J]. Mol Med Rep, 2019, 19(3): 1543-1550.
|
| [39] |
Shen J, Huang CK, Yu H, et al.The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma[J]. J Cell Mol Med, 2017, 21(5): 986-992.
|
| [40] |
Miller KD, Siegel RL, Lin CC, et al.Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin, 2016, 66(4): 271-289.
|
| [41] |
El-Serag HB.Epidemiology of viral hepatitis and hepatocellular carcinoma[J]. Gastroenterology, 2012, 142(6): 1264-1273.e1.
|
| [42] |
Yang JD, Roberts LR.Hepatocellular carcinoma: A global view[J]. Nat Rev Gastroenterol Hepatol, 2010, 7(8): 448-458.
|
| [43] |
Abdalla MA, Haj-Ahmad Y. Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients [J]. J Cancer, 2012, 3(1): 19-31.
|
| [44] |
Peng C, Ye Y, Wang Z, et al.Meta-analysis of circulating microRNAs for the diagnosis of hepatocellular carcinoma[J]. Dig Liver Dis, 2018, 卷(期): 起-止页.
|
| [45] |
Ye Y, Song Y, Zhuang J, et al.MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion[J]. Onco Targets Ther, 2018, 11: 8175-8184.
|
| [46] |
Bai S, Nasser MW, Wang B, et al.MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J]. J Biol Chem, 2009, 284(46): 32015-32027.
|
| [47] |
Xiong Y, Fang JH, Yun JP, et al.Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma[J]. Hepatology, 2010, 51(3): 836-845.
|
| [48] |
Zhang P, Yin J, Yuan L, et al.MicroRNA-139 suppresses hepatocellular carcinoma cell proliferation and migration by directly targeting Topoisomerase I[J]. Oncol Lett, 2019, 17(2): 1903-1913.
|
| [49] |
Ni JS, Zheng H, Huang ZP, et al.MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma[J]. Oncol Lett, 2019, 17(2): 2317-2327.
|